Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Comparison of the prevalence of past-year use and nonmedical use (NMU) of sedatives-hypnotics between the 2014 and 2018 waves of the national survey in Taiwan

From: Trends in the use and nonmedical use of sedatives-hypnotics in the population aged 12 to 64 years in Taiwan: a comparative analysis of the national surveys in 2014 and 2018

 

Sample size

 

Past-year use of sedatives-hypnotics

 

Past-year NMU of sedatives-hypnotics

 

2014

2018

 

2014

 

2018

Changes

(%)

DID (%)

2014

 

2018

Changes

(%)

DID

(%)

Variable

N

N

 

n

%wt (SE)

n

%wt (SE)

n

%wt (SE)

n

119 (0.67)

10 (0.28)

%wt (SE)

Total

17,837

18,626

 

836

5.46 (0.25)

896

5.23 (0.22)

-0.23

-

100

0.71 (0.10)

119

0.67 (0.08)

-0.04

-

Stratification by adulthood

              

Adolescents

4445

3598

 

15

0.42 (0.16)

22

0.80 (0.20)

0.38*

-

2

0.16 (0.14)

10

0.39 (0.15)

0.25*

-

Adults

13,392

15,028

 

821

6.00 (0.27)

874

5.63 (0.24)

-0.37

-

98

0.77 (0.11)

109

0.70 (0.09)

-0.07

-

Stratification by age groups × sex

             

18–39 years

               

 Male

2921

3366

 

80

3.07 (0.47)

71

2.29 (0.33)

-0.78¶

Ref

18

0.84 (0.28)

7

0.18 (0.08)

-0.66*

Ref

 Female

2815

3144

 

94

2.91 (0.36)

114

3.81 (0.47)

0.90¶

1.68*

24

0.72 (0.17)

24

0.62 (0.18)

-0.10

0.57

40–64 years

               

 Male

3695

4115

 

270

7.48 (0.60)

284

6.56 (0.49)

-0.92

Ref

24

0.81 (0.22)

30

0.74 (0.18)

-0.07

Ref

 Female

3961

4403

 

377

9.99 (0.66)

405

9.02 (0.55)

-0.97

-0.05

32

0.73 (0.17)

48

1.14 (0.20)

0.41¶

0.47

  1. Note: N = unweighted overall number; n = unweighted number; %wt = weighted prevalence; SE = standard error; DID = difference-in-differences of prevalence
  2. *P < 0.05 for a z-test comparing two prevalence rates or a Wald chi-square test for the DID; ¶ borderline significant at 0.05 < P < 0.06